www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
Business / Companies

Xi'an Janssen plans 10 drug launches in four areas by 2020

By Wang Wen (China Daily) Updated: 2015-10-31 09:50

Xi'an Janssen Pharmaceutical Ltd, Johnson & Johnson Services Inc's largest subsidiary in China, plans to launch more than 10 new medicines in China by 2020.

Kris Sterkens, chairman of Jassen Asia Pacific, said innovation remains its core strategy, and its products will be spread over four main treatment areas: tumors, the autoimmune system, mental health and infectious and metabolic diseases such as hepatitis and diabetes.

The firm's new-product strategy, he said, was being supported by a number of recent findings that showed China has strong demand for medicine targeted at those diseases.

A survey by the Economist Intelligence Unit, a global business intelligence belonging to the Economist Group, for instance, analyzed markets in five countries across Asia Pacific including China, and reached the conclusion that "the region now carries a huge global burden of non-communicable diseases, such as cancer and mental illness".

As many as 85 percent of deaths in China in 2010 were the result of non-communicable diseases, according to the report, with cancer, cardiovascular disease and diabetes topping the list of causes.

"Healthcare systems in Asia Pacific are struggling to manage the rise in non-communicable diseases and the shift to long-term treatment of chronic conditions," said Charles Ross, the survey report's editor.

Following on from those and other findings, Xi'an Janssen will launch a new product for prostate cancer soon, said Sterkens. Research is also being conducted on a diabetes medicine.

Xi'an Janssen has launched 14 major new products in the past five years aimed at treating conditions like human immunodeficiency virus, cancer and mental illness.

Established 30 years ago, it has been a regular investor in China since its launch.

A new $290 million plant in Xi'an will be in operation from 2018, said Cesar Rodriguez, the company's chief.

The new site will have an annual capacity of 280 million medicine packages, which will be sold around the world, said Rodriguez.

Xi'an Janssen is well known in China for over-the-counter drugs such as Domperidone and Daktarin.

Johnson & Johnson combined its OTC business in China last year with Xi'an Janssen, a controversial move at the time with some industry commentators fearing the integration might hurt sales.

Rodriguez insisted the integration, named One China OTC, has achieved strong results, although he refused to detail exact numbers.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 亚洲欧洲久久久精品 | 国产男女视频在线观看 | 免费99视频有精品视频高清 | 国产精品黄页网站在线播放免费 | 久久久久久免费精品视频 | 亚洲最大看欧美片网站 | 久久欧美成人精品丝袜 | 日韩三级中文字幕 | 操小美女| 无套内谢孕妇毛片免费看 | 农村寡妇一级毛片免费看视频 | 男女免费视频 | 豆国产97在线 | 亚洲 | 久久久久久久国产精品毛片 | 天天看片天天爽_免费播放 天天看夜夜 | 99久久这里只精品国产免费 | 日韩性大片免费 | 免费播放aa在线视频成人 | 欧美3p精品三区 | 99久久精品免费看国产四区 | 中文无码日韩欧免费视频 | 免费看一级欧美激情毛片 | 国产高清视频在线播放 | 在线看欧美日韩中文字幕 | 好爽~好硬~好紧~蜜芽 | 欧美videofree性欧美另类 | 最新国产成人综合在线观看 | 中国农村一级毛片 | 中国一级毛片录像 | 日韩免费高清一级毛片在线 | 国产呦精品一区二区三区网站 | 国产精品国三级国产aⅴ | 成年大片免费视频播放二级 | 特黄日韩免费一区二区三区 | 成人久久| 欧美亚洲免费久久久 | 欧美精品亚洲精品日韩 | 高清性色生活片欧美在线 | 五月色婷婷琪琪综合伊人 | 日韩免费高清一级毛片 | 久草视频精品在线 |